Global Biopharmaceutical Market Sales Worth to be over USD 166 Billion by 2017, Expects IMARC Group

11 Oct 2012 • by Natalie Aster

The global biopharmaceutical Industry has come a long way since its first drug - Humulin was approved in 1982. Today more than three hundred biopharmaceuticals have already been approved and many more are in late stages of clinical development. These drugs have not only advanced the prevention and treatment of a number of life threatening diseases, but have also provided the thrust for the continued success of the pharmaceutical industry.

Under mounting economic pressures to increase their outputs, pharmaceutical manufacturers have embraced biopharmaceuticals as a means to maintain flow in their drying pipelines. Bringing a biopharmaceutical, however, represents a very risky proposition as out of every ten drugs that enter the clinical phases, only three manage to gain market approval. But the industry’s US$ 109 billion figures and double digit growth rates in recent years bears a testimony to the fact that the ones that finally do get approval represent goldmines for investors.

Although factors like biosimilar entry and cost containment in the developed markets are likely to restrain the growth of this market in the coming years, biopharmaceuticals are expected to provide the industry with a huge scope for future growth due to their high potency and ability to attack targets beyond the reach of traditional small molecule drugs. A rich late stage pipeline and increasing demand in emerging markets are also expected to be major drivers in the coming years. The global biopharmaceutical market is forecast to exceed sales worth US$ 166 Billion by 2017.

IMARC’s new report “Global Biopharmaceutical Market Report & Forecast (2012-2017)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market trends, geographical structure, therapeutic structure, competitive structure and the outlook of the global biopharmaceutical market till 2017. This report will serve as an excellent guide for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the global biopharmaceutical market in any form.

Report Details:

Global Biopharmaceutical Market Report & Forecast (2012-2017)
Published: September, 2012
Pages: 238
Price: US$ 1.200,00

More information can be found in the report “Global Biopharmaceutical Market Report & Forecast (2012-2017)” by IMARC Group.

To order the report or ask for sample pages contact


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970